When the body is unable to produce or use insulin properly, glucose (sugar) builds up in the blood and damages blood vessels and nerves. This also damages the small blood vessels that nourish the retina (which senses light and sends it to your brain for translation into images).
In advanced diabetes, the damaged retinal blood vessels close off, causing the retina to create new but abnormally weak blood vessels to grow on the retina. This spurt of the new weak walled blood vessels is known as proliferative diabetic retinopathy.
Sustained high blood sugar weakens the vessel walls, making them bulge. This causes leaking and retinal swelling that's responsible for blurry vision occurring in the early stages of diabetic retinopathy.
As scar tissue accumulates, it can contract and pull the delicate underlying retinal layers away from the eyewall (known as a retinal detachment) leading to permanent vision loss. That's why proliferative diabetic retinopathy is the most common cause of vision loss among diabetics.
The biggest challenge in managing diabetic eye disease is that there are no early symptoms. During the early stages, you do not experience pain or vision changes.
If your diabetes worsens and you develop proliferative diabetic retinopathy, you may experience any of the following symptoms:
If you experience a sudden onset of any of the above symptoms or sense that a curtain has been pulled over your visual field, this can be a sign of a detached retina, a medical emergency.
The gold standard treatment for PDR and macular edema is with medications that are applied directly within the affected eye via injection.
These medications, known as the anti-VEGF class, are designed to slow the growth of abnormal blood vessels and to keep damaged vessels from leaking:
Anti-VEGF medications work by blocking a protein responsible for the growth of abnormal blood vessels (called vascular endothelial growth factor, or VEGF). These medications also stop weak vessels from leaking. Because of this, anti-VEGF treatments can prevent further vision loss and may even improve vision in some cases.
Anti-VEGF medications are administered via injection into your eye (once it has been numbed) using a very fine needle the thickness of a human hair. This is performed in our office. Typically, you are given several treatments in the first few months, and then fewer treatments over time.
While there is no cure for proliferative retinopathy, there are treatments available that can help manage the condition and prevent further vision loss. The treatment’s primary goal is to reduce abnormal blood vessel growth in the retina.
Some of the treatments available for proliferative retinopathy include laser photocoagulation, which uses a laser to seal off leaking blood vessels, and injections of medications that can help prevent the growth of new blood vessels.
To receive disability benefits, an individual must meet the Social Security Administration's (SSA) eligibility requirements. The SSA uses a strict definition of disability and considers an individual disabled if they have a medical condition that is expected to last at least one year or result in death and that prevents them from engaging in substantial gainful activity (SGA).
As diabetic retinopathy progresses, the following symptoms may occur:
Diabetic retinopathy is caused by damage to blood vessels in the retina, which is part of the eye that senses light and sends images to the brain. High blood sugar levels (hyperglycemia) are characteristic of diabetes. In addition to causing vision problems, kidney damage is another common result of elevated blood sugar levels.
The four stages of diabetic retinopathy are:
While diet can play a role in managing diabetes, it is not typically sufficient to reverse diabetic retinopathy once it has developed. Diabetic retinopathy is caused by damage to the blood vessels in the retina, which can result from high blood sugar levels over a long period. The best way to prevent and manage diabetic retinopathy is to maintain reasonable blood sugar control through a combination of healthy eating, exercise, and medication as prescribed by a healthcare provider.
The AGEI staff includes a highly-skilled retina specialist Dr. Svetlana Pilyugina or “Dr. P”, as she is known to her patients. Dr. P is a Stanford educated and fellowship-trained ophthalmologist. She is board certified in diseases and surgery of the vitreous and retina.
Dr. Pilyugina has extensive experience in the treatment of diabetic eye conditions and all other retinal conditions.
To schedule an appointment, either call 866-945-2745 or click here to make an appointment online.
As a member of an elite group of only 3000 retina-vitreous specialists in the United States, Stanford trained Dr. Pilyugina brings to AGEI a unique skill set in the treatment and surgery of retinal disease. Her academic credentials include numerous research papers, conference presentations, medical publications, and clinical trials.